Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
BeOne Medicines Ltd.
6160Health technology
$37.2B
Market Cap
Shariah Analysis
Passed
Business
Cash
Liabilities
Based on AAOIFI screening standards, BeOne Medicines Ltd. appears to be Passed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)1.20%
Non-Permissible
$48
Total Income
$3.9K
Revenue Breakdown
Product revenue, net
$3.8K
Collaboration revenue
$31
Interest income, net
Non-Operating
$48
Non-Compliant: $48
Financial Screening
FYE 2024
Cash (<30%)13.54%
Non-Shariah Cash Items
Cash And Cash Equivalents$2.6B
Restricted Cash$9.3M
Liabilities (<30%)5.55%
Non-Shariah Liabilities
Current Capital Lease Obligation$17.6M
Long Term Debt$166.5M
Long Term Capital Lease Obligation$44.3M
Current Debt$851.5M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2026-01-28
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.